Application of Clinical Genetics最新文献

{"title":"First Report from Saudi Arabia of Trimethylaminuria Caused by a Premature Stop Codon Mutation in the <i>FMO3</i> Gene.","authors":"Bandar Alghanem, Hassan S Alamri, Tlili Barhoumi, Imran Ali Khan, Khawlah Almuhalhil, Essra Aloyouni, Hayat Shaibah, Abdullah Mashhour, Shatha Algheribe, Imadul Islam, Mohamed Boudjelal, Majid Alfadhel","doi":"10.2147/TACG.S497959","DOIUrl":"https://doi.org/10.2147/TACG.S497959","url":null,"abstract":"<p><strong>Background: </strong>Trimethylaminuria (TMAU) is a rare recessive genetic disorder with limited global prevalence. To date, there have been no official reports of TMAU cases documented in Saudi Arabia.</p><p><strong>Purpose: </strong>In this study, we developed a liquid chromatography-mass spectrometry (LC-MS) method for the analysis of trimethylamine (TMA) and Trimethylamine N-Oxide (TMAO) in urine and plasma samples for the first reported case of TMAU in Saudi Arabia.</p><p><strong>Patients and methods: </strong>A 41-year-old Saudi man was diagnosed with TMAU in National Guard Hospital. Blood and urine samples were collected to confirm the diagnosis of TMAU. In this study, we have studied LC-MS, cell culture, flow cytometry, adhesion assay and Sanger sequencing analysis. Additionally, in this study, we have selected 5 healthy controls.</p><p><strong>Results: </strong>The results have revealed elevated TMA levels were present in both urine and plasma samples, while TMAO levels were significantly lower compared to control group. Further, we utilized plasma sample from the TMAU patient as novel model to investigate the potential effect of low TMAO on monocyte and endothelial cell function in vitro. DNA sequencing analysis identified a c.622G >T (p.Glu208*) which creates a premature stop codon in FMO3 gene.</p><p><strong>Conclusion: </strong>Our findings revealed differential responses in monocytes and endothelial cells stimulated with plasma from the TMAU patient compared to plasma from non-TMAU patients. These distinct responses may be key modulators of endothelial function and contributes to vascular damage.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"215-228"},"PeriodicalIF":2.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142932985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expanding the Molecular Landscape of Androgen Insensitivity Syndrome Through Next-Generation Sequencing.","authors":"Tadeusz Kałużewski, Iwona Pinkier, Urszula Wysocka, Jordan Sałamunia, Łukasz Kępczyński, Małgorzata Piotrowicz, Bogdan Kałużewski, Agnieszka Gach","doi":"10.2147/TACG.S498338","DOIUrl":"10.2147/TACG.S498338","url":null,"abstract":"<p><p>Androgen insensitivity syndrome (AIS) is an X-linked genetic disorder caused by mutations in the androgen receptor gene (<i>AR</i>), leading to impaired androgen signaling and resulting in varying degrees of undermasculinization in individuals with a 46,XY karyotype. This study aimed to expand the molecular landscape of AIS by identifying and characterizing pathogenic variants in the <i>AR</i> gene via next-generation sequencing (NGS). Molecular diagnostics revealed eight distinct variants within the <i>AR</i> gene, two of which had not been previously described. These include the following novel variants: c.3G>A, and c.1344_1345insTA. This study broadens the spectrum of known <i>AR</i> gene mutations associated with AIS and highlights the critical role of molecular diagnostics in the accurate classification of variants. These findings will aid in enhancing the clinical management and genetic counseling of individuals affected by AIS.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"205-214"},"PeriodicalIF":2.6,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142898884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bilateral Wilms Tumor - Case Report of a Patient with Family History.","authors":"Oliwia Rdzanek, Patrycja Najda, Karolina Parysek-Wójcik, Anna Pytlik, Monika Lejman, Joanna Zawitkowska","doi":"10.2147/TACG.S495498","DOIUrl":"10.2147/TACG.S495498","url":null,"abstract":"<p><p>Wilms' tumor (WT) is the most common renal neoplasm in children. Despite its rapid growth, it is often asymptomatic. It most commonly occurs between the ages of 3 and 5, more frequently in girls. Numerous studies report an association between the occurrence of Wilms' tumor and genetic background. Treatment of bilateral Wilms' tumor (BWT) presents several challenges. Recent studies raise the issue of the influence of genetics on the development of BWT. We believe that our case report is innovative as it provides information on a rare clinical presentation and comprehensively addresses the potential impact of genetic studies on favorable treatment outcomes, which are discussed only in limited detail in the literature. The case description concerns a 2-year-old and a 5-month-old patient who presented with his mother due to a change in abdominal contour. In the medical history, the boy's mother had been treated for WT. Imaging of the abdominal cavity revealed the presence of pathological tissue changes in both kidneys. Based on this, stage V Wilms' tumor was diagnosed. The boy underwent a right-sided tumor nephrectomy followed by a left-sided heminephrectomy. He also received pre- and post-operative chemotherapy. Genetic testing revealed a deletion fragment of exon 8 and exons 9-10 on one allele of the <i>WT1</i> gene. Despite optimistic data regarding overall survival in children with WT, a significant clinical issue remains with patients experiencing disease recurrence and bilateral BWT. Radical treatment is often required for such patients, which carries long-term consequences. Identifying patients at risk for familial WT or BWT allows for relatively early intervention and effective prevention. Furthermore, certain gene variants associated with WT can be considered prognostic biomarkers.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"199-203"},"PeriodicalIF":2.6,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11660652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathway of LCK Tyrosine Kinase and mTOR Signaling in Children with T-Cell Acute Lymphoblastic Leukemia.","authors":"Agata Rocka, Maria Suchcicka, Aleksandra M Jankowska, Magdalena M Woźniak, Monika Lejman","doi":"10.2147/TACG.S494389","DOIUrl":"10.2147/TACG.S494389","url":null,"abstract":"<p><p>The aim of this study is to analyze available research on targeting signaling pathways for the development of new drugs in patients with T-cell acute lymphoblastic leukemia (T-ALL). This analysis focuses specifically on the role of LCK tyrosine kinase and mTOR signaling pathways in pediatric patients. Outcome: Current literature suggests that these pathways play a significant role in the regulation of T-cell cycles, making them potential therapeutic targets. However, despite promising findings, there remains a need for further research, particularly in pediatric populations, to fully understand the therapeutic implications and to optimize drug development. The conclusion drawn from this analysis highlights the significant influence of LCK and mTOR on T-cell cycle regulation, underscoring the importance of continued investigation in this area.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"187-198"},"PeriodicalIF":2.6,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11585986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Genetic, Auditory Features, and Systemic Clinical Phenotype in 14 Families with Syndromic Hearing Loss.","authors":"Zhoushu Zheng, Lulu Yan, Lu Ding, Yinghui Zhang, Meihong Wang, Yihui Yang, Junhua Wu, Changshui Chen, Ming Tang, Haibo Li","doi":"10.2147/TACG.S472898","DOIUrl":"https://doi.org/10.2147/TACG.S472898","url":null,"abstract":"<p><strong>Introduction: </strong>Syndromic hearing loss (SHL) is characterized by distinctive clinical phenotypes as well as genetic and phenotypic heterogeneity. More than 400 species of SHL have been described, the majority of which are autosomal dominant.</p><p><strong>Methods: </strong>11 forms of SHL were obtained from 14 unrelated families with probands ranging in age from 5 to 78 months. The results of whole exome sequencing(WES), audiological characteristics, middle and inner ear radiological findings, and additional clinical phenotype characteristics were retrospectively analyzed.</p><p><strong>Results: </strong>Fourteen people with SHL were found. Two of them had Waardenburg syndrome, two had Branchio-Oto-Renal syndrome, two had CHARGE syndrome, and one had Treacher Collins syndrome, Kleefstra syndrome, Muenke syndrome, Osteopathia Striata with Cranial Sclerosis, Ayme-Gripp syndrome, Tatton-Brown-Rahman syndrome, Stickler syndrome, or Stapes Ankylosis with Broad Thumbs and Toes. In this investigation, ten variants were first reported.</p><p><strong>Discussion: </strong>The combination of a neonatal hearing screening and WES can diagnose syndrome-type hearing loss in infancy and childhood, according to our findings, expansion of the gene variant spectrum and phenotype for various age groups of SHL is essential and can provide valuable guidelines for clinical intervention decisions. It is imperative for medical practitioners to conduct diligent and prolonged patient monitoring due to the inherent variability in both the auditory impairment and the comprehensive clinical manifestation of SHL.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"171-186"},"PeriodicalIF":2.6,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of RIPK1 and RIPK2 Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Han Population.","authors":"Shuang Lv, Yiming Li, Bojian Sun, Yu Jing, Xing Wang, Zhanqing Gu, Bailiang Wang, Cheng Xiao","doi":"10.2147/TACG.S472418","DOIUrl":"https://doi.org/10.2147/TACG.S472418","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objects: &lt;/strong&gt;Rheumatoid arthritis (RA) is a systemic autoimmune disease with an obscure pathogenesis. This study aims to identify the susceptibility conferred by specific single nucleotide polymorphisms (SNPs), namely rs17548629 within the RIPK1 gene and rs10094579 within the RIPK2 gene, in RA. Additionally, it investigates the associations between inflammatory markers and biochemical parameters at various stages of the disease.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We analyzed 394 patients with RA and 258 normal controls (NCs), examining SNPs within the RIPK1 (rs17548629) and RIPK2 (rs10094579) genes using polymerase chain reaction (PCR) and sequencing techniques. Profiles of RA patients were evaluated for inflammatory markers, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), as well as biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, glucose, uric acid, and creatinine. Additionally, disease-specific indicators included cyclic citrullinated peptide (CCP), rheumatoid factor (RF), antinuclear antibodies (ANA), and anti-keratin antibodies. The Disease Activity Score 28 (DAS28), based on ESR, was used to categorize RA patients into groups of high, moderate, or low disease activity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We found a significant association between the RIPK1 rs17548629 genotype and RA in the additive model (&lt;i&gt;p&lt;/i&gt; &lt; 0.001; OR = 3.23), over-dominant model (&lt;i&gt;p&lt;/i&gt; &lt; 0.001; OR = 0.27), and dominant model (&lt;i&gt;p&lt;/i&gt; &lt; 0.001; OR = 3.94). The frequency of the C allele at rs17548629 was significantly higher in NCs than in RA patients (&lt;i&gt;p&lt;/i&gt; &lt; 0.001; OR = 0.322). When compared with normal controls, the RIPK1 rs17548629 genotype demonstrated significant associations with both anti-CCP-positive RA patients (&lt;i&gt;p&lt;/i&gt; &lt; 0.001) and anti-CCP-negative RA patients (&lt;i&gt;p&lt;/i&gt; &lt; 0.001). Similarly, this genotype was associated with RF-positive RA patients (&lt;i&gt;p&lt;/i&gt; &lt; 0.001). Furthermore, the RIPK2 rs10094579 genotype was significantly associated with CRP levels in RA patients with low disease activity in the over-dominant model (&lt;i&gt;p&lt;/i&gt; = 0.029; OR = 0.065, adjusted for age and sex).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The presence of the RIPK1 rs17548629 genotype is associated with RA under additive, co-dominant, and dominant models. The T allele mutation at rs17548629 increases the risk of RA in the Chinese population. The RIPK1 rs17548629 genotype was identified as being associated with RF-positive RA patients, whereas no significant association was observed in RF-negative individuals. These findings suggest that this SNP may modulate the risk of RA in an RF-dependent manner. Furthermore, the RIPK2 rs10094579 genotype correlates with CRP levels in RA patients exhibiting low disease activity. This association underscores the necessity for caution when reducing the dosage of therapy in RA patients with low disease activity who carry the CA genotype at RIPK2 rs10094","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"159-169"},"PeriodicalIF":2.6,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11498044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Consanguinity and Occurrence of Monogenic Diseases in a Single Tertiary Centre in Riyadh, Saudi Arabia: A 2 Years Cross-Sectional Study.","authors":"Lamia K Alshamlani, Dana S Alsulaim, Raghad S Alabbad, Ahad A Alhoshan, Joud F Alkhoder, Norah S Alsaleh, Mohammed Almannai, Faroug Ababneh, Manal Algattan, Lojain Alsini, Abdulrahman Faiz Alswaid, Wafaa M Eyaid, Fuad Al Mutairi, Muhammad Umair, Majid Alfadhel","doi":"10.2147/TACG.S476350","DOIUrl":"10.2147/TACG.S476350","url":null,"abstract":"<p><strong>Background: </strong>Consanguinity, or the practice of marrying close relatives, is a common cultural tradition in Saudi Arabia, with rates among the highest in the world. This practice has significant implications for the prevalence and distribution of major single genetic defects and chromosomal abnormalities within the Saudi population.</p><p><strong>Methods: </strong>Herein, using the BESTCare electronic medical record system (designed to streamline hospital operations, enhance patient care, and improve the overall efficiency of healthcare services; bestcare.ezcaretech.com) in a single tertiary centre, King Abdullah Specialized Children Hospital (KASCH) in Riyadh, Saudi Arabia, we performed a cross-sectional study for all patients referred to the hospital from the 1st January 2020 until 1st January 2022.</p><p><strong>Results: </strong>The present study, which included 1100 individuals, found a high prevalence of consanguinity (64%) and a significant proportion of third-degree relatives (69%). The mean age of participants was 12.24 years, and the diagnostic rate using advanced molecular genetics techniques was 45%, with whole exome sequencing (WES) being the most common method (43%). The study also noted a significant delay in diagnosis for more than a year in 16% of cases, with a common neurodevelopmental phenotype (18%).</p><p><strong>Conclusion: </strong>In conclusion, we revealed the prevalence of consanguineous marriages in the KASCH hospital in Riyadh, Saudi Arabia. We also highlighted the most frequently referred phenotype. These findings are consistent with previous research on the prevalence and impact of consanguinity on rare genetic disorders.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"151-158"},"PeriodicalIF":2.6,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Ser434Phe <i>Androgen Receptor</i> Gene Mutation Does Not Affect Fertility but is Associated with Increased Prolactin.","authors":"Nesreen A Saadeh, Marya Obeidat, Mohammad Shboul","doi":"10.2147/TACG.S466919","DOIUrl":"10.2147/TACG.S466919","url":null,"abstract":"<p><strong>Introduction: </strong>Prolactin is a hormone secreted by the anterior pituitary gland essential for lactation. Non-physiological hyperprolactinemia characterized by serum prolactin levels exceeding 20 ng/mL in men and 25 ng/mL in women, often results from medication use or pituitary gland tumors. In a minority of cases, the cause of hyperprolactinemia remains unknown despite clinical investigations. Familial idiopathic hyperprolactinemia may stem from mutations in genes encoding prolactin (<i>PRL</i>) and its receptor (<i>PRLR</i>).</p><p><strong>Methods: </strong>This study investigated genetic polymorphisms in <i>PRL</i> and <i>PRLR</i> genes using polymerase chain reaction (PCR) and Sanger sequencing in three sisters affected by familial idiopathic hyperprolactinemia. No mutations were found in these genes, prompting whole exome sequencing (WES) of the proband to identify other potentially involved genes.</p><p><strong>Results: </strong>WES revealed a heterozygous missense substitution c.1301C>T (p.Ser434Phe) in the <i>androgen receptor</i> (<i>AR</i>) gene. Next-generation sequencing (NGS) for the <i>AR</i> gene confirmed that the proband and her two affected sisters, along with three asymptomatic sisters, were all heterozygous carriers of the mutation. Their father was hemizygous, while their mother had a normal genotype.</p><p><strong>Conclusion: </strong>The heterozygous missense mutation in the <i>AR</i> gene found in this family with familial idiopathic hyperprolactinemia is not yet explained. Hence, further research is warranted to elucidate the functional implications of this mutation on AR and its role in the pathogenesis of hyperprolactinemia.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"143-149"},"PeriodicalIF":2.6,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11442143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142362184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Class II Transactivator Gene (<i>CIITA</i>) Variants Associated with Bare Lymphocyte Syndrome II in a Female Sudanese Patient.","authors":"Omaima Abdel Majeed Mohamed Salih, Nahla Hashim Hassan Erwa, Abdelrahman Hamza Abdelmoneim, Hiba Awadelkareem Osman Fadl, Brigitte Glanzmann, Manasik Abdalla Babiker Osman, Monzir Ahmed Hassan Osman, Thuraya Mohamed Elshiekh Gasim, Alamin Mustafa","doi":"10.2147/TACG.S472788","DOIUrl":"https://doi.org/10.2147/TACG.S472788","url":null,"abstract":"<p><strong>Introduction: </strong>Inborn errors of immunity (IEI) are disorders that present a health issue, especially in developing countries where there is a high rate of consanguineous marriages and an increasing rate of diagnosis. One of these disorders is Bare Lymphocyte Syndrome II (BLS II) which is a rare and genetically complex disease that has high morbidity and mortality. The exact genotypic and phenotypic characteristics are still poorly characterized especially in developing countries.</p><p><strong>Case presentation: </strong>Here, we report the first case of BLS II in a seven-month-old Sudanese female with recurrent chest infections, dermatitis, persistent diarrhea, and failure to thrive. The patient's all four sisters and three paternal uncles died in early infancy. Laboratory investigations revealed low CD3+, CD4+, and CD8+ lymphocytes, along with normal CD19+ and CD16+ lymphocytes, and low serum IgM and IgA levels. Genetic analysis revealed two <i>CIITA</i> variants; c.2296C >G p. (Pro766Ala) and c.439+1G >A.</p><p><strong>Conclusion: </strong>Further bioinformatics, immunological and clinical workups supported a pathogenic effect of both mutations affecting the function of CIITA protein, and suggesting a compound heterozygote mutation. The patient was started on prophylactic antibiotics and regular intravenous immunoglobulin replacement therapy. The prognosis of this disease is poor in most of the cases, with only a few reported cases surviving until adulthood.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"133-141"},"PeriodicalIF":2.6,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11430264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum: Sturge-Weber Syndrome: A Review of Pathophysiology, Genetics, Clinical Features, and Current Management Approache [Corrigendum].","authors":"","doi":"10.2147/TACG.S487419","DOIUrl":"https://doi.org/10.2147/TACG.S487419","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.2147/TACG.S363685.].</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":"17 ","pages":"131-132"},"PeriodicalIF":2.6,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11328840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}